The Australian Diabetes Society (ADS) develops diabetes related clinical guidelines and position statements from working parties consisting of endocrinologists, diabetes educators, general practitioners and other healthcare professionals providing their clinical expertise. The ADS established the Clinical Standards/Guidelines Advisory Committee (CAC) where the members review and provide feedback on guidelines, positions statements and consultation requests. The ADS also engages and in collaboration with other key stakeholder organisations for their professional advice on relevant publications. Endorsement by the Australian Diabetes Society and use of the ADS logo on any such publication requires that the ADS be invited and involved in the development of that particular position statement or clinical guideline.
Search results appear below the blue box
A Position Statement on Gestational Diabetes in Australia The Gestational Diabetes in Australia Position Statement has been developed by Diabetes Australia in collaboration with the Australian Diabetes Society, the Australian Diabetes
Summary A joint Position Statement by the Australian Diabetes Society, Australasian Diabetes Educators Association, Dietitians Association of Australia, Exercise and Sports Science Australia and the Pharmaceutical Society of Australia. Prediabetes has
Summary This Position Statement represents the collective views of the Australian Diabetes Society, the Australian Diabetes Educators Association and Diabetes Australia. The Therapeutic Goods Administration (TGA) recently approved the first
Summary Emergency management of hyperglycaemia in primary care was developed by the RACGP and the Australian Diabetes Society (ADS) to raise clinical awareness of hyperglycaemic emergencies in primary care by:
Authors: Roger Chen, Timothy Lambert, Jen Kinsella, Leon Chapman, Maarten Kamp, Jennifer Conn Summary The Australian Diabetes Society (ADS) has released a new Position Statement aimed at improving the management
Position Statement Download the full version of the ‘ADS Position Statement on Insulin Glargine (Lantus®) and a Possible Link with Cancer – PDF (Posted: October, 2017)
Authors: Mervyn Kyi, Barbora Paldus, Natalie Nanayakkara, Michael Bennett, Rebecca Johnson, Catherine Meehan, Peter Colman Summary In 2015 the Australian Diabetes Society commissioned a working group to review and revise
Summary These guidelines have been developed by an ADS working group and are primarily intended to provide assistance for those practitioners whose primary focus is not diabetes or who do not have the support
Summary The 2012 ADS Guidelines for Routine Glucose Control in Hospital have been developed over the last year, and cover a range of areas including general hospital wards, myocardial infarction, stroke, steroid-induced
The National evidence‐based clinical care guidelines for type 1 diabetes in children, adolescents and adults is the first national evidence‐based clinical care guideline for type 1 diabetes across the lifespan. This document was developed by an Expert Advisory Group (EAG) representing specialist societies and organisations, with the active participation of consumer groups and the community.
